Pricing

Jack A. Khattar

Founder at Supernus Pharmaceuticals, Inc.

Jack A. Khattar

Jack A. Khattar

Founder at Supernus Pharmaceuticals, Inc.

Overview

Career Highlights

Shire Laboratories, Inc.
Supernus Pharmaceuticals, Inc.

RelSci Relationships

461

Number of Boards

7

Birthday

1961

Age

59

Relationships

View Relationship Details

RelSci Relationships are individuals Jack A. Khattar likely has professional access to. A relationship does not necessarily indicate a personal connection.

John M. Siebert

Chief Operating Officer at New Rhein Healthcare LLC

Relationship likelihood: Strong

Frederick M. Hudson

Former Partner at KPMG LLP

Relationship likelihood: Strong

Charles W. Newhall III

Chairman-Emeritus at Mid-Atlantic Venture Association

Relationship likelihood: Strong

M. James Barrett

General Partner Emeritus & Strategic Adviser at New Enterprise Associates

Relationship likelihood: Strong

Padmanabh P. Bhatt

Senior Vice President, Intellectual Property & Chief Scientific Officer at Supernus Pharmaceuticals, Inc.

Relationship likelihood: Strong

Jacob Vanlandingham

Founder at Prevacus, Inc.

Relationship likelihood: Strong

Georges Gemayel

Former Executive Vice President-Therapeutics at Genzyme Corp.

Relationship likelihood: Strong

John H. Tucker

President, Chief Executive Officer, Chief Financial Officer & Director at scPharmaceuticals, Inc.

Relationship likelihood: Strong

Jonathan Silverstein

General Partner & Co-Head of Global Private Equity at OrbiMed Advisors LLC

Relationship likelihood: Strong

Gregory Patrick

Chief Financial Officer & Senior Vice President at Supernus Pharmaceuticals, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

ENP Newswire

February 27, 2020

-Supernus to Present at the 2020 Cowen Health Care Conference

ENP Newswire

February 26, 2020

-Supernus Announces Fourth Quarter and Full Year 2019 Financial Results

ENP Newswire

February 12, 2020

-Supernus to Host Fourth Quarter and Full Year 2019 Results Earnings Conference Call

ENP Newswire

January 22, 2020

-Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD

ENP Newswire

January 9, 2020

-Supernus to Present at the 2020 J.P. Morgan Healthcare Conference

Paths to Jack A. Khattar

Potential Connections via
Relationship Science

You

Jack A. Khattar

Founder at Supernus Pharmaceuticals, Inc.

Education

BBA

American University of Beirut

The American University of Beirut is a private, secular, and independent university in Beirut, Lebanon. Degrees awarded at the American University of Beirut (AUB) are officially registered with the New York Board of Regents. On April 24, 1863, the State of New York granted a charter for the Syrian Protestant College. The college, which was renamed the American University of Beirut in 1920, opened on December 3, 1866.

MBA

University of Pennsylvania - The Wharton School

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

Memberships

Member

Prior

Licensing Executives Society International

Licensing Executives Society has constructed an online presence, based upon those items in which members have expressed the most interest. The site will be easier to use, allow more members to contribute content and will allow the organization to provide world-class services to its Societies and their members, both now and in the future.

Career History

Founder

2005 - Current

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

President & Chief Executive Officer

1999 - 2005

Shire Laboratories, Inc.

Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD.

Executive Officer & Chairman

1995 - 1999

CIMA Labs, Inc.

CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN.

Boards & Committees

Member, Executive Committee

1999 - 2004

Shire Plc

Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Chairman, Management Committee

Prior

CIMA Labs, Inc.

CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN.

Transactions

Details Hidden

Supernus Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Supernus Pharmaceuticals, Inc. raised money in a private placement transaction

Investments

Details Hidden

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

Jack A. Khattar is affiliated with Supernus Pharmaceuticals, Inc., Shire Laboratories, Inc., CIMA Labs, Inc., Shire Plc, Merck & Co., Inc., Novartis Corporation, Playtex Products LLC, Kodak Ltd., Shire Plc, CIMA Labs, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jack A. Khattar. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jack A. Khattar's profile does not indicate a business or promotional relationship of any kind between RelSci and Jack A. Khattar.